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Abstract
Background In up to 4% of laparoscopic Roux-en-Y gastric
bypass (LRYGB) procedures, anastomotic leaks occur.
Early detection of gastrointestinal leakage is important for
successful treatment. Consequently, many centers advocate
routine postoperative upper gastrointestinal (UGI) series.
The aim of this study was to determine the utility of this
practice after LRYGB.
Methods Eight hundred four consecutive patients undergo-
ing LRYGB from June 2000 to April 2010 were analyzed
prospectively. The first 382 patients received routine UGI
series between the third and fifth postoperative days (group
A). Thereafter, the test was only performed when clinical
findings (tachycardia, fever, and drainage content) were
suspicious for a leak of the gastrointestinal anastomosis
(group B; n=422).
Results Overall, nine of 804 (1.1%) patients suffered from
leaks at the gastroenterostomy. In group A, four of 382
(1%) patients had a leak, but only two were detected by the
routine UGI series. This corresponds to a sensitivity of
50%. In group B, the sensitivity was higher with 80%.
Specificities were comparable with 97% and 91%, respec-
tively. Routine UGI series cost only 1.6% of the overall
costs of a non-complicated gastric bypass procedure. With
this leak rate and sensitivity, US $86,800 would have to be
spent on 200 routine UGI series to find one leak which is
not justified.
Conclusions This study shows that routine UGI series have
a low sensitivity for the detection of anastomotic leaks after
LRYGB. In most cases, the diagnosis is initiated by clinical
findings. Therefore, routine upper gastrointestinal series are
of limited value for the diagnosis of a leak.
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Introduction
Morbid obesity has reached a high prevalence in the western
world and is associated with a number of concomitant health
risks such as type II diabetes, hypertension, hyperlipid-
emia, coronary artery disease, and obstructive sleep apnea
[1, 2]. Conservative treatment of morbid obesity has failed
to show good results regarding long-term weight loss
and reduction of co-morbidities [3–5]. Today, the most
efficient treatment with proven long-term results is gastric
bypass surgery [5].
Laparoscopic Roux-en-Y gastric bypass (LRYGB) was
introduced by Wittgrove and Clark in 1994 [6] and is
presently the most widely used procedure besides laparo-
scopic gastric banding worldwide. Several prospective,
randomized clinical trials have demonstrated that LRYGB
results in less blood loss, less pain medication require-
ments, shorter length of hospitalization, shorter return to
daily activities, and fewer complications compared with an
open approach [7–10]. However, LRYGB is associated
with a number of complications [11]. One of the most
serious complications is a leakage at the gastrojejunostomy,
which occurs in approximately 2–4.4% of LRYGB proce-
dures [12, 13]. It has been shown that early detection and
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treatment is of paramount importance in order to reduce
morbidity and mortality in the further course [14].
Unfortunately, detection of such leaks is a challenge in
obese patients [15]. Therefore, some surgeons have sug-
gested the use of a routine postoperative upper gastrointes-
tinal (UGI) series to detect a potential leakage [11, 12, 14,
16]. Medicolegal issues further support the use of a routine
UGI series. However, the usefulness of routinely performed
tests after LRYGB is discussed controversial because of
additional costs and lack of sensitivity [15, 17]. Moreover,
the timing of the routine UGI series and occurrence of leaks
is undetermined.
The evidence in the literature from large single institu-
tional series is sparse as only small series have been
reported using UGI contrast studies following LRYGB [16,
17]. In fact, as new bariatric programs emerge in face of the
growing epidemic of obesity, many surgeons might think
that routine UGI series increase the patient’s safety.
Therefore, we evaluated the utility of routine upper
gastrointestinal series after LRYGB using a prospective
database of 804 consecutive patients operated at our
institution. In addition, this study provides a cost analysis
on the use of routine postoperative UGI series.
Patients and Methods
Eight hundred four consecutive patients undergoing a
LRYGB from June 2000 to April 2010 were analyzed
using a prospectively collected database. In the first 382
patients routine, UGI series was performed between the
third and fifth postoperative days (group A, n=382). From
May 2005 onwards, we stopped the performance of routine
UGI series and used an intraoperative methylene blue test
to assess the gastrojejunostomy in every patient instead
(group B, n=422). UGI series were only performed when
clinical findings (tachycardia, fever, drainage content, and
reduced general condition) were suspicious for a leakage of
the gastrojejunostomy in this group. In group B, 16 upper
gastrointestinal series (and additionally six computed
tomography (CT) scans) were performed upon clinical
findings suggesting a leakage. All radiology reports were
reviewed and evaluated for effectiveness for detection of
postoperative complications and anastomotic leaks.
Reports, which raised a high suspicion for a leakage, were
defined as test positive. Operative findings clearly showing
a leak at the gastrojejunostomy, or clinical findings—
including fever, tachycardia, and pain—and amylase-rich
drainage fluid (amylase >200 U/l for more than 3 days) or
obvious aspect of intestinal contents within the drain over
days served as a gold standard for the definition of a
leakage. The interval between the operation and time of
diagnosis was calculated. Sensitivity, specificity, positive
predictive value, and negative predictive value were
calculated.
Cost Analysis
We calculated the overall cost of LRYGB in patients
without complications and compared it to those of LRYGB
in patients with a leak at the gastrojejunostomy. Costs of
routine UGI series were also calculated.
Surgical Technique
All gastric bypass procedures were performed laparoscopi-
cally as described by Wittgrove in 1994. Briefly, a small
gastric pouch of 15–25 ml is created. Next, the jejunum is
divided 50 ml distally to the duodenojejunal flexure, and
the jejunojejunostomy is performed using a linear stapler.
The mesenteric window at the jejunojejunostomy is closed
with a non-absorbable suture (Ethibond™). Either an
alimentary limb length of 150 cm in the proximal bypass
or a common channel of 150 cm in the distal bypass is
chosen, depending on the preoperative body mass index
(BMI). The alimentary limb is then brought up to the
gastric pouch. The gastrojejunal anastomosis is performed
with a circular stapling device (CEEA 25-mm, Tyco,
Mansfield, MA), which is inserted transabdominally. In
group B, intraoperatively, methylene blue is injected via a
nasogastric tube into the proximal stomach pouch. Simul-
taneously, the distal jejunum is occluded to create pressure
on the gastric staple line and the gastrojejunal anastomosis.
Leaks may be identified visually with extrusion of
methylene blue.
Fig. 1 Normal postoperative contrast study
OBES SURG (2011) 21:1238–1242 1239
Upper Gastrointestinal Series
An UGI contrast study was routinely performed between
the third and fifth postoperative days in group A. For this
imaging study the patient was placed in a semi-upright
position. Approximately 60 ml of water soluble Gastro-
grafin (diatrizoate meglumine and diatrizoate sodium;
Bracco Diagnostics, Princeton, NJ, USA) was administered
orally. Videofluoroscopy is performed as the contrast is
administered, and fluoroscopic spot films are obtained.
Overhead films are made in the anteroposterior (AP) and
right and left posterior oblique positions to evaluate passage
of contrast through the esophagus and gastric pouch
(Figs. 1 and 2). Then 15 min later, an additional AP film
is taken to asses emptying of the pouch, passage of contrast
through the jejunum, reflux into the duodenum, and possible
delayed leak. All films were assessed by one of the staff
radiologists. In group B, the upper GI series were performed
upon a clinical suspicion for a leakage; in six cases, an
additional CT scan was performed when the upper gastroin-
testinal series findings were unclear.
Results
Patient’s characteristics are presented in (Table 1). There was
no significant difference between the two patient groups
regarding, age, gender, BMI, or operative procedure.
In nine of 804 (1.1%) patients a leak was diagnosed
upon operative results and clinical findings. In group A,
leaks occurred in four out of 382 (1.0%) patients. In group
B, five out of 422 (1.2%) patients presented with a leakage.
There was no difference in the prevalence of leakages
between the two groups (Fisher’s exact test, p=1.000). The
leakages of the gastrojejunostomy were confirmed during
surgery in seven patients and via analysis of the drainage
content in two patients, who were treated conservatively
with antibiotics and drainage. Among the seven patients
who needed surgery for the leakage, two were operated
laparoscopically and five underwent a laparotomy. One
patient had a leak confirmed at surgery although the upper
gastrointestinal series were negative, but deteriorated
clinically. The interval between the operation and the time
of diagnosis was between 2 and 9 days. The difference
between the time intervals to diagnosis was not different in
the two groups. In group A, the mean time interval was
5 days, and in group B it was 4.25 days (median 4.5 in both
groups, p=0.743). Therefore, omitting routine UGI series
did not delay the diagnosis of a leakage. Three leakages
occurred on the fifth postoperative day, three on the second,
the remaining on the third, fourth, and ninth postoperative
days. All patients with a leakage suffered either from fever,
severe pain, or tachycardia.
Of the four patients who developed a leakage in group
A, two were detected by the UGI series (Table 2). However,
Fig. 2 Leak with extravasation of contrast
Total Group A Group B p
n 804 382 422
Age (years) 41.0 (10.6) 41.3 (10.4) 40.7 (10.7) 0.425
Female 485 (74.2%) 275 (72%) 325 (77%) 0.105
Male 169 (25.8%) 107 (28%) 97 (23%)
Weight (kg) 128.3 (24.6) 128.5 (24.0) 128.2 (25.5) 0.784
Mean BMI (kg/m2) 45.9 (7.3) 46.0 (7.2) 45.7 (7.4) 0.523
OP type (n)
Primary LRYGB 632 (79%) 304 (80%) 328 (78%) 0.135
Conversion from Gastric Banding 155 (19%) 74 (19%) 81 (19%)
Primary ORYGB 17 (2%) 4 (1%) 13 (3%)
Leak 9 (1.1%) 4 (1%) 5 (1.2%) 1.000
Time to diagnosis of leak (days) 4.5 5 4.25 0.743
Table 1 Patients’ characteristics
Values are given in mean±SD.
Chi-square test was used to
compare sex and type of
operation, independent t test
for comparing means for age,
weight, and BMI.
LRYGB laparoscopic Roux-en-Y
Gastric Bypass, ORYGB Open
Roux-en-Y Gastric Bypass
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both tests have been performed earlier than scheduled
due to clinical symptoms. The other two leakages were
missed on the contrast study, and in nine patients in
group A the contrast study was false positive. This
results in a sensitivity and specificity of 50% and 97%
for routine upper gastrointestinal series, compared with
80% and 91% in group B (Table 3). In group B, 16 upper
gastrointestinal series and additionally six CT scans with
oral contrast have been performed upon clinical suspicion
for a leakage. These tests correctly identified five leaks
and missed one. Sensitivity and specificity are given in
Table 3.
Cost Analysis
The mean (SD) overall costs for UGI in patients without
leakage at the gastrojejunostomy was US $26,426 (5,927;
n=795). In the presence of a leakage at the gastro-
jejunostomy, expenses increased dramatically with a mean
costs of US $80,980 (56,543; n=9). The cost of a routine
UGI series was US $434 (which corresponds to approxi-
mately 334 euros), only 1.6% of the overall costs of a non-
complicated gastric bypass procedure.
With a leak rate of 1% and a sensitivity of 50%, one
would have to do 200 tests and to spend US $86,800 on
routine upper gastrointestinal series to pick one leak and
could still not assume that the cost would be diminished in
this case, not to mention the missed case with a false-
negative test. Of note, the difference between a standard
uncomplicated gastric bypass procedure and a case with a
leak at this hospital is US $54,554.
Discussion
Patients undergoing LRYGB develop early postoperative
complications in up to 15% [18]. Most common complica-
tions include port site infections, intra-abdominal abscess
formation, and less frequent leakage of the gastrojejunos-
tomy. Early detection and treatment of these complications
has been reported to have a positive impact on the patients’
outcome [19]. The incidence of gastrojejunal leakages
occurs in up to 4.4% [12, 13]. Usually, the leakage is
located at the gastrojejunostomy and can result in signifi-
cant morbidity with prolonged hospital stay. Early detection
of gastrointestinal leakage is of paramount importance in
order to treat this severe complication adequately [14].
Upper gastrointestinal series are widely used on a routine
basis in the postoperative period. It allows visualization of
the gastric proximal pouch and provides information about
size and position and potential leakage. Consequently,
many centers, initially also our center, have suggested
using a postoperative UGI contrast study on a routine basis
[20]. However, the use of such tests on a routine basis after
LRYGB is controversially discussed because of the
additional costs and technical/methodological limitations,
e.g., difficulties in monitoring contrast in obese patients
[15, 17, 21–23]. In this study, we have shown that routine
upper gastrointestinal series have a very low sensitivity to
detect a leakage at the gastrojejunostomy and did not result
in an earlier detection of the leakage. In fact in some
patients where the leakages have been diagnosed correctly
with routine UGI series, the tests have been performed
earlier than scheduled due to clinical symptoms. The other
two leakages were missed by the UGI series and in addition
there were nine false-positive tests. The sensitivity of the
upper gastrointestinal series was higher when performed
under clinical suspicion for a leakage.
Omitting routine upper gastrointestinal series did not
delay the time to diagnosis, and therefore did not have any
negative impact on the patients’ management and outcome.
Furthermore, the incidence of detected leakages was the
same with or without routine upper gastrointestinal series.
Therefore, we suggest that routine UGI series can be
omitted in high-volume institutions and be replaced by
Leak Confirmed None
Group A: patients with routinely performed postoperative UGI series following LRYGB
Test positive 2 9
Test negative 2 361
Group B: patients with a postoperative UGI series only when clinical findings were found
Test positive 4a 1
Test negative 1 10b
Table 2 UGI series
a One case was additionally
confirmed on CT scan
b Five cases were additionally
confirmed on CT scan
Table 3 Sensitivity, specificity, positive predictive value, and nega-
tive predictive value
Sens (%) Spec (%) PPV (%) NPV (%)
Group A 50 97 18 99
Group B 80 91 80 91
Sens sensitivity, Spec specificity, PPV positive predictive value, NPV
negative predictive value
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tests, which are performed selectively upon clinical suspi-
cion for a leakage, as has also been shown by Lee et al. in a
smaller series [24]. In units with an evolving bariatric
program, routine UGI series might still be valuable at least
for medicolegal issues. In the recent period, we have
performed contrast-enhanced CT scan with oral contrast
upon clinical findings, which provides further information
such as the presence of intra-abdominal abscesses.
The presence of a leakage results in considerable
higher costs compared with costs in patients with an
uneventful postoperative course. The costs for the UGI
series is only a small part of the whole cost for a bypass
procedure. However, since this procedure did not result
in a faster recognition of the complication, economically
spoken, the routine UGI series does not make sense and
increases the costs for a bypass procedure without any
further benefit. Even if one assumes that an early
detection of a leak with an upper gastrointestinal series
would defer the course to a comparable one without a
leak, with a test sensitivity of only 50% it would not be
economical as shown in our cost analysis. Therefore, we
omit the routine test and perform tests upon postopera-
tive clinical findings in our daily practice.
This study shows that routine upper gastrointestinal
series have a low sensitivity for the detection of anasto-
motic leakages after laparoscopic gastric bypass surgery
and is also economically not justified. Omitting routine
UGI series did not result in a delay of the diagnosis of
anastomotic leakage. Therefore, in our opinion UGI series
on a routine basis is no longer recommended in high-
volume institutions.
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